FDA Inspection 793421 — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited — FEI 3004664162

The FDA completed an inspection of Takeda Pharmaceutical Company Limited on Jul 20, 2012 in Hikari. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 20, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hikari (Japan)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.